<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02666937</url>
  </required_header>
  <id_info>
    <org_study_id>2014.524 (A2015.361)</org_study_id>
    <nct_id>NCT02666937</nct_id>
  </id_info>
  <brief_title>Safe Limits in Saturation in the ICU (SLIM-study)</brief_title>
  <acronym>SLIM</acronym>
  <official_title>Safe Limits in Saturation in the ICU (SLIM-study)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>VU University Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>VU University Medical Center</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      A study consisting of a prospective and retrospective cohort in the ICU, ER and pulmonary
      department in a university hospital in Amsterdam and a teaching hospital in Alkmaar, the
      Netherlands.

      The relationship between the oxygen saturation measured by pulse-oximetry and the arterial
      PaO2 is investigated in order to investigate which transcutaneous saturation values are safe
      when administering oxygen in relation to hyperopia and hypoxia.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This study consists of two parts a prospective and a retrospective part.

        1. Prospective part: Patients in the ICU, the emergency room and the pulmonary function
           department of the VU university medical centre will be included. Arterial blood gas
           analysis is a tool often used to determine PaO2 in regular care. When an arterial blood
           gas analysis is performed for regular patient care, the corresponding SpO2 is measured.
           Information such as blood pressure, heart rate, amount of administered fluids and
           shock-related-parameters are obtained from the patient files. For the ICU patients
           capillary refill, acra temperature and the mottling scores are examined. The peripheral
           flow index and temperature index is measured. When more arterial blood gas samples are
           drawn over time in one patient, multiple datasets can be included per patient, as long
           as the samples are drawn two hours apart.

        2. Retrospective part: Patients with a (suspected) pulmonary disease who underwent
           pulmonary function tests with arterial bloodgas sampling in the VU medical center and
           Medical Centre Alkmaar in the last 25 years. The PaO2 and corresponding SpO2 will be
           obtained from the test and parameters such as blood pressure, heart rate and
           administered oxygen will be retrieved from the databases with these test results.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">December 2015</start_date>
  <completion_date type="Actual">August 2017</completion_date>
  <primary_completion_date type="Actual">August 2017</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Other</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Relation SpO2-PaO2</measure>
    <time_frame>Average of one week</time_frame>
    <description>To determine peripherally measured saturation targets between which no hyperoxia and hypoxia will occur</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Factors influencing PaO2-Spo2 relation</measure>
    <time_frame>Average of one week</time_frame>
    <description>To identify factors influencing the relationship between SpO2 and PaO2, such as hemodynamics, peripheral circulation, shock and pH</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Relation in SpO2-PaO2 in different populations</measure>
    <time_frame>Average of one week</time_frame>
    <description>To determine differences in the SpO2/PaO2 -relationship in different populations</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Differences in relation in SpO2-PaO2 prospective versus retrospective</measure>
    <time_frame>Average of one week</time_frame>
    <description>To determine differences in the SpO2/PaO2 -relationship in a prospective and a retrospective cohort</description>
  </secondary_outcome>
  <number_of_groups>4</number_of_groups>
  <enrollment type="Actual">879</enrollment>
  <condition>Critical Illness</condition>
  <condition>Hyperoxia</condition>
  <condition>Hypoxia</condition>
  <arm_group>
    <arm_group_label>ICU-patients (prospective)</arm_group_label>
    <description>Critically ill patients (18 years and older) on mechanically ventilation who have an arterial line and require bloodgasanalysis for medical reasons</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Emergency Department (prospective)</arm_group_label>
    <description>Patients (18 years and older), who are presented to the Emergency Department, and require bloodgasanalysis for medical reasons</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Pulmonary department (prospective)</arm_group_label>
    <description>Patients (18 years and older) who visit the outpatient clinic of the pulmonary department for different pulmonary functional test and require bloodgasanalysis for medical reasons</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Pulmonary department (retrospective)</arm_group_label>
    <description>Patients (18 years and older) who visited the outpatient clinic of the pulmonary department in the past of the VU medical centre in Amsterdam or the Medical Centre Alkmaar for different pulmonary functional test and required bloodgasanalysis for medical reasons</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        Prospective

          -  ICU - VUmc: Critically ill patients, requiring invasive monitoring

          -  Pulmonary function department - VUmc: Patients requiring a pulmonary function test
             with arterial bloodgas analysis.

          -  ER VUmc: Patients presented at the shockroom or patients in the general ER, requiring
             arterial bloodgas analysis.

        Retrospective

        - Pulmonary function departments: Patients who underwent a pulmonary function test with
        arterial bloodgas analysis in the last 25 years.
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion criteria for all inclusions:

          -  Age: 18&gt;

          -  Requiring arterial bloodgas analysis

        Exclusion criteria for all inclusions:

          -  Hyperbilirubinemia (&gt;20 Î¼mol/L)

          -  CO-Hb (&gt;1,5%)

          -  MetHb (&gt;1,5%)

          -  Unreliable pulsatile SpO2 curve

        Additional inclusion criteria:

        - Prospective, ICU - VUmc: On mechanical ventilation. Arterial line in place.

        Additional exclusion criteria:

          -  Prospective, ICU - VUmc: On extracorporeal membrane oxygenation. Therapeutic
             hypothermia.

          -  Retrospective, Pulmonary function departments: Uncertainty whether SpO2 was measured
             exactly during arterial bloodgas sampling.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Angelique ME Spoelstra - de Man, Phd Md</last_name>
    <role>Study Director</role>
    <affiliation>VU University Medical Center</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>VUMedicalCentre</name>
      <address>
        <city>Amsterdam</city>
        <state>Noord-Holland</state>
        <zip>1007 MB</zip>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Netherlands</country>
  </location_countries>
  <link>
    <url>http://www.oximetry.org/pulseox/principles.htm</url>
    <description>Principles of oximetry</description>
  </link>
  <reference>
    <citation>Cornet AD, Kooter AJ, Peters MJ, Smulders YM. Supplemental oxygen therapy in medical emergencies: more harm than benefit? Arch Intern Med. 2012 Feb 13;172(3):289-90. doi: 10.1001/archinternmed.2011.624. Epub 2012 Jan 9. Review.</citation>
    <PMID>22231614</PMID>
  </reference>
  <reference>
    <citation>de Jonge E, Peelen L, Keijzers PJ, Joore H, de Lange D, van der Voort PH, Bosman RJ, de Waal RA, Wesselink R, de Keizer NF. Association between administered oxygen, arterial partial oxygen pressure and mortality in mechanically ventilated intensive care unit patients. Crit Care. 2008;12(6):R156. doi: 10.1186/cc7150. Epub 2008 Dec 10.</citation>
    <PMID>19077208</PMID>
  </reference>
  <reference>
    <citation>Austin MA, Wills KE, Blizzard L, Walters EH, Wood-Baker R. Effect of high flow oxygen on mortality in chronic obstructive pulmonary disease patients in prehospital setting: randomised controlled trial. BMJ. 2010 Oct 18;341:c5462. doi: 10.1136/bmj.c5462.</citation>
    <PMID>20959284</PMID>
  </reference>
  <reference>
    <citation>Kilgannon JH, Jones AE, Shapiro NI, Angelos MG, Milcarek B, Hunter K, Parrillo JE, Trzeciak S; Emergency Medicine Shock Research Network (EMShockNet) Investigators. Association between arterial hyperoxia following resuscitation from cardiac arrest and in-hospital mortality. JAMA. 2010 Jun 2;303(21):2165-71. doi: 10.1001/jama.2010.707.</citation>
    <PMID>20516417</PMID>
  </reference>
  <reference>
    <citation>Kuisma M, Boyd J, Voipio V, AlaspÃ¤Ã¤ A, Roine RO, Rosenberg P. Comparison of 30 and the 100% inspired oxygen concentrations during early post-resuscitation period: a randomised controlled pilot study. Resuscitation. 2006 May;69(2):199-206. Epub 2006 Feb 24.</citation>
    <PMID>16500018</PMID>
  </reference>
  <reference>
    <citation>Bellomo R, Bailey M, Eastwood GM, Nichol A, Pilcher D, Hart GK, Reade MC, Egi M, Cooper DJ; Study of Oxygen in Critical Care (SOCC) Group. Arterial hyperoxia and in-hospital mortality after resuscitation from cardiac arrest. Crit Care. 2011;15(2):R90. doi: 10.1186/cc10090. Epub 2011 Mar 8.</citation>
    <PMID>21385416</PMID>
  </reference>
  <reference>
    <citation>Meyhoff CS, Jorgensen LN, Wetterslev J, Christensen KB, Rasmussen LS; PROXI Trial Group. Increased long-term mortality after a high perioperative inspiratory oxygen fraction during abdominal surgery: follow-up of a randomized clinical trial. Anesth Analg. 2012 Oct;115(4):849-54. Epub 2012 Jul 13.</citation>
    <PMID>22798533</PMID>
  </reference>
  <reference>
    <citation>Quintard H, Patet C, Suys T, Marques-Vidal P, Oddo M. Normobaric hyperoxia is associated with increased cerebral excitotoxicity after severe traumatic brain injury. Neurocrit Care. 2015 Apr;22(2):243-50. doi: 10.1007/s12028-014-0062-0.</citation>
    <PMID>25168744</PMID>
  </reference>
  <reference>
    <citation>Rincon F, Kang J, Maltenfort M, Vibbert M, Urtecho J, Athar MK, Jallo J, Pineda CC, Tzeng D, McBride W, Bell R. Association between hyperoxia and mortality after stroke: a multicenter cohort study. Crit Care Med. 2014 Feb;42(2):387-96. doi: 10.1097/CCM.0b013e3182a27732.</citation>
    <PMID>24164953</PMID>
  </reference>
  <reference>
    <citation>Baleeiro CE, Wilcoxen SE, Morris SB, Standiford TJ, Paine R 3rd. Sublethal hyperoxia impairs pulmonary innate immunity. J Immunol. 2003 Jul 15;171(2):955-63.</citation>
    <PMID>12847267</PMID>
  </reference>
  <reference>
    <citation>Davis WB, Rennard SI, Bitterman PB, Crystal RG. Pulmonary oxygen toxicity. Early reversible changes in human alveolar structures induced by hyperoxia. N Engl J Med. 1983 Oct 13;309(15):878-83.</citation>
    <PMID>6888481</PMID>
  </reference>
  <reference>
    <citation>Jackson RM. Pulmonary oxygen toxicity. Chest. 1985 Dec;88(6):900-5. Review.</citation>
    <PMID>3905287</PMID>
  </reference>
  <reference>
    <citation>Fracica PJ, Knapp MJ, Piantadosi CA, Takeda K, Fulkerson WJ, Coleman RE, Wolfe WG, Crapo JD. Responses of baboons to prolonged hyperoxia: physiology and qualitative pathology. J Appl Physiol (1985). 1991 Dec;71(6):2352-62.</citation>
    <PMID>1778933</PMID>
  </reference>
  <reference>
    <citation>Harten JM, Anderson KJ, Angerson WJ, Booth MG, Kinsella J. The effect of normobaric hyperoxia on cardiac index in healthy awake volunteers. Anaesthesia. 2003 Sep;58(9):885-8.</citation>
    <PMID>12911363</PMID>
  </reference>
  <reference>
    <citation>Lodato RF. Decreased O2 consumption and cardiac output during normobaric hyperoxia in conscious dogs. J Appl Physiol (1985). 1989 Oct;67(4):1551-9.</citation>
    <PMID>2793757</PMID>
  </reference>
  <reference>
    <citation>Haque WA, Boehmer J, Clemson BS, Leuenberger UA, Silber DH, Sinoway LI. Hemodynamic effects of supplemental oxygen administration in congestive heart failure. J Am Coll Cardiol. 1996 Feb;27(2):353-7.</citation>
    <PMID>8557905</PMID>
  </reference>
  <reference>
    <citation>Zwemer CF, Whitesall SE, D'Alecy LG. Cardiopulmonary-cerebral resuscitation with 100% oxygen exacerbates neurological dysfunction following nine minutes of normothermic cardiac arrest in dogs. Resuscitation. 1994 Mar;27(2):159-70. Erratum in: Resuscitation 1994 May;27(3):267.</citation>
    <PMID>8086011</PMID>
  </reference>
  <reference>
    <citation>O'Driscoll BR, Howard LS, Davison AG; British Thoracic Society. BTS guideline for emergency oxygen use in adult patients. Thorax. 2008 Oct;63 Suppl 6:vi1-68. doi: 10.1136/thx.2008.102947. Erratum in: Thorax. 2009 Jan;64(1):91.</citation>
    <PMID>18838559</PMID>
  </reference>
  <reference>
    <citation>Decalmer S, O'Driscoll BR. Oxygen: friend or foe in peri-operative care? Anaesthesia. 2013 Jan;68(1):8-12. doi: 10.1111/anae.12088. Epub 2012 Nov 7.</citation>
    <PMID>23130783</PMID>
  </reference>
  <reference>
    <citation>Suzuki S, Eastwood GM, Glassford NJ, Peck L, Young H, Garcia-Alvarez M, Schneider AG, Bellomo R. Conservative oxygen therapy in mechanically ventilated patients: a pilot before-and-after trial. Crit Care Med. 2014 Jun;42(6):1414-22. doi: 10.1097/CCM.0000000000000219.</citation>
    <PMID>24561566</PMID>
  </reference>
  <reference>
    <citation>Sinex JE. Pulse oximetry: principles and limitations. Am J Emerg Med. 1999 Jan;17(1):59-67. Review.</citation>
    <PMID>9928703</PMID>
  </reference>
  <reference>
    <citation>Nitzan M, Romem A, Koppel R. Pulse oximetry: fundamentals and technology update. Med Devices (Auckl). 2014 Jul 8;7:231-9. doi: 10.2147/MDER.S47319. eCollection 2014. Review.</citation>
    <PMID>25031547</PMID>
  </reference>
  <reference>
    <citation>Swain DP, Pittman RN. Oxygen exchange in the microcirculation of hamster retractor muscle. Am J Physiol. 1989 Jan;256(1 Pt 2):H247-55.</citation>
    <PMID>2912188</PMID>
  </reference>
  <reference>
    <citation>Jensen LA, Onyskiw JE, Prasad NG. Meta-analysis of arterial oxygen saturation monitoring by pulse oximetry in adults. Heart Lung. 1998 Nov-Dec;27(6):387-408.</citation>
    <PMID>9835670</PMID>
  </reference>
  <reference>
    <citation>Astiz ME, Rackow EC, Kaufman B, Falk JL, Weil MH. Relationship of oxygen delivery and mixed venous oxygenation to lactic acidosis in patients with sepsis and acute myocardial infarction. Crit Care Med. 1988 Jul;16(7):655-8.</citation>
    <PMID>3371040</PMID>
  </reference>
  <reference>
    <citation>van Genderen ME, Lima A, Bakker J, van Bommel J. [Peripheral circulation in critically ill patients: non-invasive methods for the assessment of the peripheral perfusion]. Ned Tijdschr Geneeskd. 2013;157(9):A5338. Review. Dutch.</citation>
    <PMID>23446154</PMID>
  </reference>
  <reference>
    <citation>House JR, Tipton MJ. Using skin temperature gradients or skin heat flux measurements to determine thresholds of vasoconstriction and vasodilatation. Eur J Appl Physiol. 2002 Nov;88(1-2):141-5. Epub 2002 Sep 3.</citation>
    <PMID>12436282</PMID>
  </reference>
  <reference>
    <citation>Sessler DI. Skin-temperature gradients are a validated measure of fingertip perfusion. Eur J Appl Physiol. 2003 May;89(3-4):401-2; author reply 403-4. Epub 2003 Mar 25.</citation>
    <PMID>12736848</PMID>
  </reference>
  <reference>
    <citation>Durlinger EMJ, Spoelstra-de Man AME, Smit B, de Grooth HJ, Girbes ARJ, Oudemans-van Straaten HM, Smulders YM. Hyperoxia: At what level of SpO(2) is a patient safe? A study in mechanically ventilated ICU patients. J Crit Care. 2017 Jun;39:199-204. doi: 10.1016/j.jcrc.2017.02.031. Epub 2017 Mar 2.</citation>
    <PMID>28279497</PMID>
  </reference>
  <verification_date>February 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 30, 2015</study_first_submitted>
  <study_first_submitted_qc>January 25, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 28, 2016</study_first_posted>
  <last_update_submitted>February 22, 2018</last_update_submitted>
  <last_update_submitted_qc>February 22, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">February 26, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>VU University Medical Center</investigator_affiliation>
    <investigator_full_name>Angelique Spoelstra-de Man</investigator_full_name>
    <investigator_title>Dr. A.M.E. Spoelstra-âde Man</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hypoxia</mesh_term>
    <mesh_term>Critical Illness</mesh_term>
    <mesh_term>Hyperoxia</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

